Consensus statement on 21-hydroxylase deficiency from the European Society for Paediatric Endocrinology and the Lawson Wilkins Pediatric Endocrine Society
about
sameAs
Consensus statement on management of intersex disordersDisorders of sexual differentiation: II. Diagnosis and treatmentCongenital Adrenal Hyperplasia: Review from a Surgeon's Perspective in the Beginning of the Twenty-First CenturyManagement of adolescents with congenital adrenal hyperplasiaLow-dose dexamethasone therapy from infancy of virilizing congenital adrenal hyperplasiaNonclassic congenital adrenal hyperplasiaA Summary of the Endocrine Society Clinical Practice Guidelines on Congenital Adrenal Hyperplasia due to Steroid 21-Hydroxylase DeficiencyTreatment and health outcomes in adults with congenital adrenal hyperplasia.The hunt for a selective 17,20 lyase inhibitor; learning lessons from nature.Congenital adrenal hyperplasia and P450 oxidoreductase deficiency.Etiological classification and clinical assessment of children and adolescents with disorders of sex development.Prenatal pharmacotherapy for fetal anomalies: a 2011 update.Disorders of sex development.A Greek girl with 11β-hydroxylase deficiency due to compound heterozygosity for two novel mutations in CYP11B1 gene.Prenatal diagnosis and treatment of congenital adrenal hyperplasia.A Gender Assessment Team: experience with 250 patients over a period of 25 years.Congenital adrenal hyperplasia: a lifelong disorder.Adult consequences of congenital adrenal hyperplasia.Congenital primary adrenal insufficiency and selective aldosterone defects presenting as salt-wasting in infancy: a single center 10-year experience.Management of 21-hydroxylase deficiency congenital adrenal hyperplasia: A survey of Canadian paediatric endocrinologists.Long-term Follow up of Congenital Adrenal Hyperplasia Patients with Hyponatremia.Defects of steroidogenesis.Clinical outcomes in the management of congenital adrenal hyperplasia.Issues in the diagnosis and management of disorders of sexual development.Nonclassic congenital adrenal hyperplasia due to 21-hydroxylase deficiency: clinical presentation, diagnosis, treatment, and outcome.The clinical use of corticosteroids in pregnancy.Two brothers with non-classical 21-hydroxylase deficiency: to treat or not to treat?Neonatal screening for congenital adrenal hyperplasia in North-Eastern Italy: a report three years into the program.Congenital adrenal hyperplasia in adulthood: do men need to continue treatment?Health-related quality of life in children with disorders of sex development (DSD).Still concerned.A case of 3beta-hydroxysteroid dehydrogenase type II (HSD3B2) deficiency picked up by neonatal screening for 21-hydroxylase deficiency: difficulties and delay in etiologic diagnosis.Complement 4 phenotypes and genotypes in Brazilian patients with classical 21-hydroxylase deficiency.Epidemiology and initial management of ambiguous genitalia at birth in Germany.Scalp hair 17-hydroxyprogesterone and androstenedione as a long-term therapy monitoring tool in congenital adrenal hyperplasia.In case you missed it: thePrenatal Diagnosiseditors bring you the most significant advances of 2014
P2860
Q24675420-9726C24D-4126-4E6B-8271-4D5FB39FA6BAQ26853190-384ED51A-9226-42EB-B62D-22621AE9F1DDQ27008282-447880AB-5433-4F48-ACB0-8BF676FEDCD6Q27025013-AA3B7117-18A2-4CCC-9DFC-E6EA7AD1FBC9Q33633351-FCCB151B-5754-4575-AEEA-FCE3C0C30212Q34021657-DB804846-0038-41A3-9CA5-86FB12B3150FQ34239089-01C7E8D5-7FFE-4829-9867-5A1CE8969645Q34392232-F8A295B1-6503-4464-ACFB-6F472DFD0235Q34525556-27A6C3F0-B123-46C5-A1A6-13F7CBA5BB19Q34602068-DA78A43F-F699-4E4D-9CB3-C81044857391Q35058047-EECFB756-F396-4AE8-BB35-F4D23C63EA12Q35230878-36EC57F5-33CA-4F56-BEFE-70A7FA7A647BQ35738207-E8201F86-8F23-4C6E-9AF4-F885E5EF15E0Q36226658-417A6BBC-236F-495C-A007-62D63DDE6EDBQ36626403-C3C42659-E818-47F1-990F-D796E1B00A4BQ36851912-03B78C7C-11E3-4AA0-8D51-835622A4D668Q37050048-7F5650D0-E5B7-4A21-9D9A-F41F88449605Q37050106-190DBBD5-C509-4E54-9DF7-C8AE17B50231Q37148459-FDD36C47-B9AE-4A7C-91A2-3E715A71A2BCQ37295033-C075639A-0D6C-40B7-BCDD-85593455A307Q37489113-06EC465C-0356-42D6-8874-2CF9AF36D8A1Q37700091-2F2F9315-3153-476D-A331-1FA0240B6AE2Q37974156-DD2E39BB-91D7-4A3F-9F52-87CCB147AC75Q38139870-B1E61E9F-5CD6-4FAA-8D22-72464FF6FE9FQ38529981-C3961FDB-A428-476B-AB0C-8562721E757EQ38641374-EA846AD0-9A04-4F14-9F9E-692A6C277E4AQ45113354-979642D1-4A8C-4B69-B8B4-0B7AB81751FEQ46428052-95099986-315C-4DFE-9FA2-D4D083017304Q46802971-AEE84D4B-F3ED-43F0-987F-79D6B76CBFEBQ48089222-982F88D5-3131-40CC-9F4E-C5540BBBDF1FQ48801376-E5805C02-242F-445F-A508-56BDEAA347C5Q50775778-3C0CAFEC-01F2-4D44-88E2-ACD76E18AE19Q51663372-DE5F4244-F7B1-495C-8573-FFE110BD398CQ51793180-3AA6B1BF-2A67-4DF6-8604-67D01DCDBBC0Q53696661-3BC78912-CB56-4995-BBDA-8B2CE3C16144Q57839575-6E37F453-74A0-4822-81BE-EB3B5F73574D
P2860
Consensus statement on 21-hydroxylase deficiency from the European Society for Paediatric Endocrinology and the Lawson Wilkins Pediatric Endocrine Society
description
2002 nî lūn-bûn
@nan
2002 թուականին հրատարակուած գիտական յօդուած
@hyw
2002 թվականին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Consensus statement on 21-hydr ...... ns Pediatric Endocrine Society
@ast
Consensus statement on 21-hydr ...... ns Pediatric Endocrine Society
@en
Consensus statement on 21-hydr ...... ns Pediatric Endocrine Society
@nl
type
label
Consensus statement on 21-hydr ...... ns Pediatric Endocrine Society
@ast
Consensus statement on 21-hydr ...... ns Pediatric Endocrine Society
@en
Consensus statement on 21-hydr ...... ns Pediatric Endocrine Society
@nl
prefLabel
Consensus statement on 21-hydr ...... ns Pediatric Endocrine Society
@ast
Consensus statement on 21-hydr ...... ns Pediatric Endocrine Society
@en
Consensus statement on 21-hydr ...... ns Pediatric Endocrine Society
@nl
P2093
P3181
P356
P1433
P1476
Consensus statement on 21-hydr ...... ns Pediatric Endocrine Society
@en
P2093
E Martin Ritzén
Phyllis W Speiser
Sharon E Oberfield
Walter L Miller
Wolfgang G Sippell
P304
P3181
P356
10.1159/000065490
P407
P577
2002-01-01T00:00:00Z